ID FXL17_HUMAN Reviewed; 701 AA. AC Q9UF56; A1A4E3; DT 01-MAR-2004, integrated into UniProtKB/Swiss-Prot. DT 05-MAY-2009, sequence version 3. DT 10-JUN-2026, entry version 188. DE RecName: Full=F-box/LRR-repeat protein 17 {ECO:0000303|PubMed:24035498}; DE AltName: Full=F-box and leucine-rich repeat protein 17 {ECO:0000305}; DE AltName: Full=F-box only protein 13 {ECO:0000250|UniProtKB:Q9QZN1}; GN Name=FBXL17 {ECO:0000303|PubMed:24035498, GN ECO:0000312|HGNC:HGNC:13615}; GN Synonyms=FBL17 {ECO:0000312|HGNC:HGNC:13615}, FBX13 GN {ECO:0000250|UniProtKB:Q9QZN1}, FBXO13 {ECO:0000312|HGNC:HGNC:13615}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Cerebellum; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M., RA Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T., RA Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., RA Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R., RA Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L., RA Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N., RA Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., RA Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., RA Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP FUNCTION, IDENTIFICATION IN THE SCF(FBXL17) COMPLEX, AND SUBCELLULAR RP LOCATION. RX PubMed=24035498; DOI=10.1016/j.molcel.2013.08.018; RA Tan M.K., Lim H.J., Bennett E.J., Shi Y., Harper J.W.; RT "Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in RT NRF2 activation via BACH1 repressor turnover."; RL Mol. Cell 52:9-24(2013). RN [7] RP FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SUFU. RX PubMed=27234298; DOI=10.15252/embj.201593374; RA Raducu M., Fung E., Serres S., Infante P., Barberis A., Fischer R., RA Bristow C., Thezenas M.L., Finta C., Christianson J.C., Buffa F.M., RA Kessler B.M., Sibson N.R., Di Marcotullio L., Toftgaard R., RA D'Angiolella V.; RT "SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and RT medulloblastoma development."; RL EMBO J. 35:1400-1416(2016). RN [8] RP FUNCTION, VARIANT ARG-627, AND CHARACTERIZATION OF VARIANT ARG-627. RX PubMed=30190310; DOI=10.1126/science.aap8236; RA Mena E.L., Kjolby R.A.S., Saxton R.A., Werner A., Lew B.G., Boyle J.M., RA Harland R., Rape M.; RT "Dimerization quality control ensures neuronal development and survival."; RL Science 362:eaap8236-eaap8236(2018). CC -!- FUNCTION: Substrate-recognition component of the SCF(FBXL17) E3 CC ubiquitin ligase complex, a key component of a quality control pathway CC required to ensure functional dimerization of BTB domain-containing CC proteins (dimerization quality control, DQC) (PubMed:30190310). FBXL17 CC specifically recognizes and binds a conserved degron of non-consecutive CC residues present at the interface of BTB dimers of aberrant CC composition: aberrant BTB dimer are then ubiquitinated by the CC SCF(FBXL17) complex and degraded by the proteasome (PubMed:30190310). CC The ability of the SCF(FBXL17) complex to eliminate compromised BTB CC dimers is required for the differentiation and survival of neural crest CC and neuronal cells (By similarity). The SCF(FBXL17) complex mediates CC ubiquitination and degradation of BACH1 (PubMed:24035498, CC PubMed:30190310). The SCF(FBXL17) complex is also involved in the CC regulation of the hedgehog/smoothened (Hh) signaling pathway by CC mediating the ubiquitination and degradation of SUFU, allowing the CC release of GLI1 from SUFU for proper Hh signal transduction CC (PubMed:27234298). The SCF(FBXL17) complex mediates ubiquitination and CC degradation of PRMT1 (By similarity). {ECO:0000250|UniProtKB:B1H1X1, CC ECO:0000250|UniProtKB:Q9QZN1, ECO:0000269|PubMed:24035498, CC ECO:0000269|PubMed:27234298, ECO:0000269|PubMed:30190310}. CC -!- SUBUNIT: Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase CC complex SCF(FBXL17) composed of CUL1, SKP1, RBX1 and FBXL17 CC (PubMed:24035498). Interacts with BTB domain-containing proteins such CC as KLHL12, BCL6 and BACH1; specifically recognizes and binds a CC conserved degron of non-consecutive residues present at the interface CC of BTB dimers of aberrant composition (PubMed:30190310). Interacts with CC SUFU (PubMed:27234298). Interacts with PRMT1 (By similarity). CC {ECO:0000250|UniProtKB:Q9QZN1, ECO:0000269|PubMed:24035498, CC ECO:0000269|PubMed:27234298, ECO:0000269|PubMed:30190310}. CC -!- INTERACTION: CC Q9UF56; Q8NFY9: KBTBD8; NbExp=3; IntAct=EBI-8835653, EBI-21328977; CC Q9UF56; Q53G59: KLHL12; NbExp=11; IntAct=EBI-8835653, EBI-740929; CC Q9UF56; P63208: SKP1; NbExp=17; IntAct=EBI-8835653, EBI-307486; CC Q9UF56; Q9UBP0: SPAST; NbExp=3; IntAct=EBI-8835653, EBI-1222832; CC Q9UF56; Q9UBP0-1: SPAST; NbExp=4; IntAct=EBI-8835653, EBI-36485974; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24035498}. Nucleus CC {ECO:0000269|PubMed:24035498, ECO:0000269|PubMed:27234298}. CC Note=Present in the cytoplasm and nucleus; more abundant in the CC cytoplasm. {ECO:0000269|PubMed:24035498}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q9UF56-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9UF56-3; Sequence=VSP_037034; CC Name=3; CC IsoId=Q9UF56-2; Sequence=VSP_037034, VSP_009476; CC -!- SIMILARITY: Belongs to the FBXL17 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK126722; BAC86658.1; -; mRNA. DR EMBL; AL133602; CAB63737.2; -; mRNA. DR EMBL; AC008462; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC011419; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471086; EAW49061.1; -; Genomic_DNA. DR EMBL; BC126144; AAI26145.1; -; mRNA. DR EMBL; BC126146; AAI26147.1; -; mRNA. DR CCDS; CCDS54886.1; -. [Q9UF56-1] DR PIR; T43444; T43444. DR RefSeq; NP_001156787.2; NM_001163315.3. [Q9UF56-1] DR PDB; 6W66; X-ray; 3.21 A; B=310-701. DR PDB; 6WCQ; EM; 8.50 A; B=310-701. DR PDB; 8UAH; EM; 3.30 A; B=310-701. DR PDB; 8UBT; EM; 3.10 A; C=310-701. DR PDB; 8UBU; EM; 4.60 A; D/K=310-701. DR PDB; 8UBV; EM; 4.10 A; B/H=310-701. DR PDBsum; 6W66; -. DR PDBsum; 6WCQ; -. DR PDBsum; 8UAH; -. DR PDBsum; 8UBT; -. DR PDBsum; 8UBU; -. DR PDBsum; 8UBV; -. DR AlphaFoldDB; Q9UF56; -. DR EMDB; EMD-21617; -. DR EMDB; EMD-42064; -. DR EMDB; EMD-42102; -. DR EMDB; EMD-42105; -. DR EMDB; EMD-42106; -. DR SMR; Q9UF56; -. DR BioGRID; 122315; 89. DR ComplexPortal; CPX-2773; SCF E3 ubiquitin ligase complex, FBXL17 variant. DR FunCoup; Q9UF56; 1517. DR IntAct; Q9UF56; 49. DR NDEx; IQUERY-CP-FBXL17; 2 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000437464; -. DR GlyGen; Q9UF56; 3 sites, 1 O-linked glycan (1 site). DR iPTMnet; Q9UF56; -. DR PhosphoSitePlus; Q9UF56; -. DR SwissPalm; Q9UF56; -. DR BioMuta; FBXL17; -. DR DMDM; 229462981; -. DR jPOST; Q9UF56; -. DR MassIVE; Q9UF56; -. DR PaxDb; 9606-ENSP00000437464; -. DR PeptideAtlas; Q9UF56; -. DR ProteomicsDB; 84171; -. [Q9UF56-1] DR ProteomicsDB; 84172; -. [Q9UF56-2] DR ProteomicsDB; 84173; -. [Q9UF56-3] DR Pumba; Q9UF56; -. DR Antibodypedia; 25280; 121 antibodies from 17 providers. DR DNASU; 64839; -. DR Ensembl; ENST00000542267.7; ENSP00000437464.2; ENSG00000145743.18. [Q9UF56-1] DR GeneID; 64839; -. DR KEGG; hsa:64839; -. DR MANE-Select; ENST00000542267.7; ENSP00000437464.2; NM_001163315.3; NP_001156787.2. DR UCSC; uc003kon.5; human. [Q9UF56-1] DR AGR; HGNC:13615; -. DR ClinPGx; PA134920563; -. DR CTD; 64839; -. DR DisGeNET; 64839; -. DR GeneCards; FBXL17; -. DR HGNC; HGNC:13615; FBXL17. DR HPA; ENSG00000145743; Low tissue specificity. DR MIM; 609083; gene. DR OpenTargets; ENSG00000145743; -. DR VEuPathDB; HostDB:ENSG00000145743; -. DR eggNOG; KOG1947; Eukaryota. DR GeneTree; ENSGT00940000156973; -. DR HOGENOM; CLU_024577_3_0_1; -. DR InParanoid; Q9UF56; -. DR OMA; MGWIPSM; -. DR OrthoDB; 550575at2759; -. DR PAN-GO; Q9UF56; 2 GO annotations based on evolutionary models. DR PhylomeDB; Q9UF56; -. DR PathwayCommons; Q9UF56; -. DR Reactome; R-HSA-9708530; Regulation of BACH1 activity. DR SignaLink; Q9UF56; -. DR SIGNOR; Q9UF56; -. DR Agora; ENSG00000145743; -. DR BioGRID-ORCS; 64839; 21 hits in 1166 CRISPR screens. DR ChiTaRS; FBXL17; human. DR GenomeRNAi; 64839; -. DR Pharos; Q9UF56; Tbio. DR PRO; PR:Q9UF56; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q9UF56; protein. DR Bgee; ENSG00000145743; Expressed in left ventricle myocardium and 201 other cell types or tissues. DR ExpressionAtlas; Q9UF56; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB. DR GO; GO:0007399; P:nervous system development; ISS:UniProtKB. DR GO; GO:0014033; P:neural crest cell differentiation; ISS:UniProtKB. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB. DR GO; GO:0006515; P:protein quality control for misfolded or incompletely synthesized proteins; IDA:UniProtKB. DR GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB. DR GO; GO:0008589; P:regulation of smoothened signaling pathway; IMP:UniProtKB. DR GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR CDD; cd22092; F-box_FBXO13; 1. DR FunFam; 3.80.10.10:FF:000161; F-box/LRR-repeat protein 17 isoform X1; 1. DR FunFam; 3.80.10.10:FF:000358; F-box/LRR-repeat protein 17 isoform X1; 1. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 2. DR InterPro; IPR036047; F-box-like_dom_sf. DR InterPro; IPR001810; F-box_dom. DR InterPro; IPR050648; F-box_LRR-repeat. DR InterPro; IPR057207; FBXL15_LRR. DR InterPro; IPR001611; Leu-rich_rpt. DR InterPro; IPR006553; Leu-rich_rpt_Cys-con_subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR PANTHER; PTHR13382:SF72; F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; 1. DR PANTHER; PTHR13382; MITOCHONDRIAL ATP SYNTHASE COUPLING FACTOR B; 1. DR Pfam; PF12937; F-box-like; 1. DR Pfam; PF13516; LRR_6; 1. DR Pfam; PF25372; LRR_FBXL15; 1. DR SMART; SM00256; FBOX; 1. DR SMART; SM00367; LRR_CC; 11. DR SUPFAM; SSF81383; F-box domain; 1. DR SUPFAM; SSF52047; RNI-like; 1. DR PROSITE; PS50181; FBOX; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; Neurogenesis; Nucleus; KW Proteomics identification; Reference proteome; Ubl conjugation pathway. FT CHAIN 1..701 FT /note="F-box/LRR-repeat protein 17" FT /id="PRO_0000119865" FT DOMAIN 318..365 FT /note="F-box" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00080" FT REGION 1..20 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 72..94 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 227..300 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1..11 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 227..237 FT /note="Gly residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 252..264 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 1..398 FT /note="Missing (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005" FT /id="VSP_037034" FT VAR_SEQ 657..701 FT /note="NEVTVEQLVQQYPHITFSTVLQDCKRTLERAYQMGWTPNMSAASS -> RVD FT YQVVCFLHISIVNSLMSYPLSFSISTPVYYILYIHFICIYAIIAMHCLPAFVN (in FT isoform 3)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_009476" FT VARIANT 627 FT /note="C -> R (impaired ability to bind substrate FT proteins)" FT /evidence="ECO:0000269|PubMed:30190310" FT /id="VAR_081000" FT HELIX 321..323 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 326..333 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 338..342 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 345..347 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 350..356 FT /evidence="ECO:0007829|PDB:8UBT" FT TURN 359..361 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 364..366 FT /evidence="ECO:0007829|PDB:6W66" FT TURN 371..373 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 378..384 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 389..392 FT /evidence="ECO:0007829|PDB:6W66" FT HELIX 401..403 FT /evidence="ECO:0007829|PDB:8UBT" FT TURN 404..406 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 407..410 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 416..418 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 427..436 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 442..444 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 453..462 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 468..470 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 479..487 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 494..497 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 505..511 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 520..523 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 530..533 FT /evidence="ECO:0007829|PDB:8UBT" FT TURN 534..538 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 544..546 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 556..562 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 570..572 FT /evidence="ECO:0007829|PDB:6W66" FT HELIX 581..590 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 596..598 FT /evidence="ECO:0007829|PDB:6W66" FT HELIX 608..615 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 621..623 FT /evidence="ECO:0007829|PDB:6W66" FT TURN 632..634 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 635..641 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 646..648 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 660..667 FT /evidence="ECO:0007829|PDB:8UBT" FT STRAND 672..674 FT /evidence="ECO:0007829|PDB:6W66" FT TURN 676..681 FT /evidence="ECO:0007829|PDB:8UBT" FT HELIX 682..687 FT /evidence="ECO:0007829|PDB:8UBT" SQ SEQUENCE 701 AA; 75695 MW; 87B7792A9357C94C CRC64; MGHLLSKEPR NRPSQKRPRC CSWCRRRRPL LRLPRRTPAK VPPQPAAPRS RDCFFRGPCM LCFIVHSPGA PAPAGPEEEP PLSPPPRDGA YAAASSSQHL ARRYAALAAE DCAAAARRFL LSSAAAAAAA AASASSPASC CKELGLAAAA AWEQQGRSLF LASLGPVRFL GPPAAVQLFR GPTPSPAELP TPPEMVCKRK GAGVPACTPC KQPRCGGGGC GGGGGGGGGG GPAGGGASPP RPPDAGCCQA PEQPPQPLCP PPSSPTSEGA PTEAGGDAVR AGGTAPLSAQ QQHECGDADC RESPENPCDC HREPPPETPD INQLPPSILL KIFSNLSLDE RCLSASLVCK YWRDLCLDFQ FWKQLDLSSR QQVTDELLEK IASRSQNIIE INISDCRSMS DNGVCVLAFK CPGLLRYTAY RCKQLSDTSI IAVASHCPLL QKVHVGNQDK LTDEGLKQLG SKCRELKDIH FGQCYKISDE GMIVIAKGCL KLQRIYMQEN KLVTDQSVKA FAEHCPELQY VGFMGCSVTS KGVIHLTKLR NLSSLDLRHI TELDNETVME IVKRCKNLSS LNLCLNWIIN DRCVEVIAKE GQNLKELYLV SCKITDYALI AIGRYSMTIE TVDVGWCKEI TDQGATLIAQ SSKSLRYLGL MRCDKVNEVT VEQLVQQYPH ITFSTVLQDC KRTLERAYQM GWTPNMSAAS S //